Skip to main content

Ariadne's European Facility Will Be Located in Madrid, Spain

NEW YORK (GenomeWeb News) — Ariadne Genomics on June 1 opened an office in Madrid to manage European sales and marketing and to support and train clients, a company official confirmed today.
The company yesterday said it plans to open an office in Europe but did not say where.
It is currently hiring sales and support staff for the office. Also, it plans to relocate a US-based lead-application scientist to the new facility, after which time that facility itself will be moved, company spokeswoman Natalia Alexandrova said in an e-mail.  
Ariadne also said that former Integromics CEO Olivier Brun will run the European operations.

Filed under

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.